Atlanta, GA – According to filings with the U.S. Securities and Exchange Commission, Oncology Analytics is raising $27,999,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Rick Dean played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Oncology Analytics

Oncology Analytics, Inc. provides health plans with an evidence-based, technologically driven approach to utilization management, which is purpose-built for oncology. Used by physicians to support over 2.5 million health plan members in the US and Puerto Rico, our e-Prior Authorization platform is updated daily to accurately reflect more than 6,000 oncology treatment protocols for anti-cancer treatment across all cancer types and stages, including chemotherapy, radiation therapy, precision medicine, targeted therapy and supportive care.

To learn more about Oncology Analytics, visit http://www.oncologyanalytics.com/

Contact:
Rick Dean, Chief Executive Officer
888-916-2616
rdean@oncologyanalytics.com
https://www.linkedin.com/in/rickjdean/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved